PharmaShots | Incisive News in 3 Shots

Subscribe Now

Bio-Thera Solutions

Bio-Thera Solutions Demonstrated High Similarity Between BAT1706, a proposed biosimilar of bevacizumab and Reference Bevacizumab

Bio-Thera Solutions Demonstrated High Similarity Between BAT1706, a proposed biosimilar of bevacizumab and Reference Bevacizumab

July 27, 2023

Bio-Thera Solutions Expands its Collaboration with Biomm for BAT2206 (biosimilar, ustekinumab)

Bio-Thera Solutions Expands its Collaboration with Biomm for BAT2206 (biosimilar, ustekinumab)

June 19, 2023

Bio-Thera Solutions Reports First Patient Dosing of BAT8007 in P-I Clinical Study for the Treatment of Advanced Solid Tumors

Bio-Thera Solutions Reports First Patient Dosing of BAT8007 in P-I Clinical Study for the Treatment of Advanced Solid Tumors

March 14, 2023

Bio-Thera Solutions Receives the NMPA’s Approval of BAT1806, a Biosimilar to Actemra

Bio-Thera Solutions Receives the NMPA’s Approval of BAT1806, a Biosimilar to Actemra

January 16, 2023

Insights+ Key Biosimilars Events of November 2022

Insights+ Key Biosimilars Events of November 2022

December 1, 2022

Bio-Thera Solutions Reports an Initiation of P-III Clinical Trial of BAT2306, a Proposed Biosimilar of Cosentyx (secukinumab) for Plaque Psoriasis

Bio-Thera Solutions Reports an Initiation of P-III Clinical Trial of BAT2306, a Proposed Biosimilar of Cosentyx (secukinumab) for...

November 1, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us